🇺🇸 FDA

Intelligence Platform

Patents

Browse 37 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9770507

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9757454

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9737600

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9731008

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9731009

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9724415

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9724414

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707293

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682145

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9382317

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9346880

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340612

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340611

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted